Mahazarin Ginwalla

Crowd cheering for the #SELECTTrial! Once weekly #semaglutide in patients with pre-existing CVD and overweight or obesity who don’t have diabetes reduced the risk of #cardiovascular death, MI, and non-fatal stroke by 20%, with NNT of 67! Super impressive findings #AHA23 #AHA2023

Grateful for the opportunity to discuss the potential of #ArtificialIntelligence in #heartfailure @HFSA -Many applications - Overlapping features w traditional statistics - Several limitations - Potential far from met Look forward to @mitchpsotka @janewilcox debate #HFSA2023

#HFSA2023. Great panel discussion on Genetics and HF. Consider genetic testing and counseling for all Nonischemic patients. More to come for the future on understanding genetic underpinnings and hopefully genetic modulation therapy. @mahwash_kassi @kamos16

Heart #transplantation from DCD? Safe strategy to expand donor pool: outcomes noninferior vs DBD! 🏥 385 adult heart-only Tx (largest single-center study), Jan 2020-Jan 2023 🫀122 DCDD grafts, younger/fewer comorbidities vs DBD 🩸83% recovered with NRP 📉DCD recipients less often hospitalized preTx/less likely to require preTx tMCS vs DBD recipients 📊no significant differences in 1y survival, severe PGD, treated rejection during first year, likelihood of allograft vasculopathy at 1y . outcomes among DCD recipients are noninferior to those of DBD recipients. @JACCJournals 🖇️bit.ly/3Q2b1Be 🖋️With editorial by @spinneymd & @mrchrtfaildoc bit.ly/3PIboiP & podcast 🎙️bit.ly/3Q42tbZ

Congrats to incoming President of @HFSA — @JamesCFangMD 🎉 🍾 #HFSA2023

Today we honor the 2023 HFSA Lifetime Achievement Award winner @rcstarling, MD, MPH, FACC, FAHA, FESC, FHFSA! This award recognizes the significant and sustained contribution he has made to the field of heart failure. Congratulations 👏 @ClevelandClinic @CleClinicHVTI #HFSA2023

Interested in tricuspid regurgitation and its cardiorenal consequences? Check out our new review! Thankful for this amazing team, turning challenges into opportunities. Proud of our HF fellows!!🔝🔝@jbroseta @caravaca_pedro @IForado @JGuzmanBofarull @dianarodespi @YasMoayedi

🔍 Exciting session on iron deficiency in Heart Failure! Key takeaways: 1️⃣ Check Fe studies: Tsat and Ferritin 2️⃣ Benefits irrespective of Hb 3️⃣ IV iron for replete iron stores only 4️⃣ Expect improved QOL, 6MWT, reduced hospitalizations, and CV mortality. #HFSA2023 @noshreza

Differentiation between Worsening HF (Trajectory) and Decompensated HF(Threshold for escalated and rescue therapy). Also response to GDMT important Responsive to GDMT: Improving/in Remission Nonresponsive to GDMT: Persistent HF/ WHF @JACCJournals #JACCHF jacc.org/doi/10.1016/j.…

Read our perspective on current crisis in #AHFTC led by #EmanHamad @shelleyhallmd @Jcontreras75 @docbhardwaj @JCardFail 🎯Practice Model, Compensation, Work life balance, curriculum reform & pathways & lack of exposure during Gen Cards need attention 👉 sciencedirect.com/science/articl…

A must-read for clinicians who treat HF🫀shock, emphasizing best practices: 🔑Early identification (often subtle in SCAI B) 🔑Hemodynamic profiling of shock with PAC 🔑 Hemodynamically-targeted therapy 🔑 Decongestion 🔑 Early MCS 🔗 bit.ly/3py8V1y

Outstanding review!!! Cardiac Myosin Inhibitors for Managing Obstructive HCM with algorithm jacc.org/doi/full/10.10… @CarolynHoMD @akshaydesaimd @anita_deswal @yaleHFdoc @DrNasrien @MinnowWalsh @paheidenreich @spinneymd @mvaduganathan

@Sadeer_AlKindi @ACCinTouch @HarringtonHVI Well deserved! Congratulations 🎉

I am thankful for the @ACCinTouch and my mentor Dr Rajagopalan @HarringtonHVI. Honored to win the ACC YIA the second time

@robmentz @ankeetbhatt @mvaduganathan @Rishidesai11 @dranulala @HFSA @DrMarthaGulati @ShelleyZieroth @AndrewJSauer @ShashankSinhaMD @QuentinYoumans @vbluml @noshreza @FudimMarat ARNI initiation should not be stalled BB initiation should not be stalled MRA initiation should not be stalled SGLT2I initiation should not be stalled

Concern over AKI might stall effective HFrEF implementation Now at JCF: In >25,000 Medicare beneficiaries w HFrEF, hosp for AKI no different in those w de-novo ARNI vs. RASi initiation @ankeetbhatt @mvaduganathan @Rishidesai11 @scottdsolomon @gcfmd @JCardFail onlinejcf.com/article/S1071-…

#DrKateKlein CT Surgeon Intensivist discusses our ⁦@IHVInews⁩ #ShockTeam Approach How should we manage CS 2/2 #AMI vs #HeartFailure? ⁦@InovaHealth⁩ ⁦@coconnormd⁩ ⁦@behnam_tehrani⁩ ⁦@agtruesdell⁩ ⁦@mpsotka⁩ ⁦@cmrosner⁩ ⁦⁦@vbluml⁩

Optimal implementation of GDMT for HFrEF could save ~100,000 additional lives a year in the US Yet, inertia defeats the best intentions of clinicians and health systems with delays, gaps, variations, and inequitable use #HFWeek2023

Thank you @CircAHA @SanaAlkhatib9 for inviting us to contribute to the 2023 @GoRedForWomen issue!All cardiologists have a role to ⬇️maternal mortality! @HeartOTXHeartMD @CardioNerds @HeartBobH @cardio10s @dmljmd @NMHheartdoc @WomenAs1 @Drroxmehran @RBP0612 @MonSangh @kevindharker